A new Japanese study ties “statistically significant” increases in particular kinds of cancers in the country in the period 2020-2022 to the administration of mRNA vaccines. These cancers include ovarian cancer, leukemia, prostate cancer, pancreatic cancer and breast cancer. Importantly, the study demonstrates that neither COVID-19 itself nor “reduced cancer care” as a result of the lockdowns is likely to be responsible for these increases.
The study’s abstract explains the motivation for the study, which begins with the observation that significant increases in excess cancer deaths were observed after the first year of the pandemic.
“No significant excess mortality was observed during the first year of the pandemic (202. However, some excess cancer mortalities were observed in 2021 after mass vaccination with the first and second vaccine doses, and significant excess mortalities were observed for all cancers and some specific types of cancer (including ovarian cancer, leukemia, prostate cancer, lip/oral/pharyngeal cancer, pancreatic cancer, and breast cancer) after mass vaccination with the third dose in 2022,” the abstract explains.